The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.

The new Wegovy is for people who never thought they would use a GLP-1 — whether they just had a baby or are going into ...

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel about exercise, and in some cases, reshaping a relationship long defined by ...

BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy ...

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in ...

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Zepbound, Wegovy and other GLP-1 drugs reduce the urge to eat everything on one’s plate, but ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A pharmacist displays a box of Wegovy (semaglutide) pills at a pharmacy in Provo, Utah, on ...